Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage.

World journal of gastroenterology - 21 Sept 2006

Derbala M F, Al Kaabi S R, El Dweik N Z, Pasic F, Butt M T, Yakoob R, Al-Marri A, Amer A M, Morad N, Bener A

Abstract excerpt

AIM: To evaluate pegylated interferon alpha2a (PegIFN-alpha2a) in Egyptian patients with HCV genotype 4, and the impact of pretreatment viral load, co-existent bilharziasis and histological liver changes on response rate. METHODS: A total of 73 naive patients (61 with history of bilharziasis) with compensated chronic HCV genotype 4 were enrolled into: group A (38 patients) who received 180 mg PegIFN-alpha2a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Ribavirin

Share to Schistosomiasis

Source

Open in PubMed Open full text

Identifiers

PMID: 17007024
DOI: 10.3748/wjg.v12.i35.5692
PMCID: PMC4088172

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage.PMID 17007024Read ↗

Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.Semantic proximity Read ↗

Efficacy and safety of a novel pegylated interferon alpha-2a in Egyptian patients with genotype 4 chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.Semantic proximity Read ↗

Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4.Semantic proximity Read ↗

Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.Semantic proximity Read ↗

Histomorphological changes in hepatitis C non-responders with respect to viral genotypes.Semantic proximity Read ↗

Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon.Semantic proximity Read ↗

Can zinc levels predict response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 4 infected Egyptian patients?Semantic proximity Read ↗

Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt.Semantic proximity Read ↗

Effect of schistosomiasis and hepatitis on liver disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.